Skip to content

Study · Not a test of the peptide alone · 2004

5 results

[The application efficacy of immunomodulators in complex of treatment of an acute necrotic pancreatitis].

Kopchak VM, Khomiak IV, Stasenko AA, Todurov IM, Kopchak KV

Klinichna khirurhiia1 Sept 2004

PMID15560588 (opens in a new tab)PepBankPUB-15560588
Publisher pageAsk about this study
Jump to 5 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone5

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with acute necrotic pancreatitis, complex treatment including immunocorrecting therapy with thymalin was reported effective for immune state, prophylaxis of purulent-septic complications and an abortive disease course.

    In plain wordsIn patients with acute necrotic pancreatitis, complex treatment including thymalin was reported effective for immune state, preventing complications and an abortive course.

    Peptide
    Thymalin
    Outcome
    Direction not reportedEfficacy of immunocorrecting therapy (immune state, purulent-septic complication prophylaxis, abortive course)
    Study

    n = 18

    Outcome group
    Overall treatment effect · Gastrointestinal

    Source sentences

    Summary
    Efficacy of immunocorrecting therapy in the immune state improvement, purulent-septic complications prophylaxis, the abortive course of the disease promotion was established
    1 context sentence
    Summary · context
    Analysis of efficacy of the immunomodulators application, thymalin in particular, in complex treatment algorhythm in 18 patients with an acute necrotic pancreatitis was conducted.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In acute necrotic pancreatitis, disease regression occurred in 12 patients during complex treatment with immunomodulators including thymalin.

    In plain wordsIn patients with acute necrotic pancreatitis, disease regression occurred in 12 patients during complex treatment including thymalin.

    Peptide
    Thymalin
    Outcome
    IncreaseDisease regression
    Study

    n = 18

    Outcome group
    Overall treatment effect · Gastrointestinal

    Measurements

    Patients with disease regression
    12 patients
    complex treatment including thymalin
    Disease regression proportion
    66.7%
    complex treatment including thymalin

    Source sentences

    Summary
    In 12 (66.7) patients the disease regression was noted
    1 context sentence
    Summary · context
    Analysis of efficacy of the immunomodulators application, thymalin in particular, in complex treatment algorhythm in 18 patients with an acute necrotic pancreatitis was conducted.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In acute necrotic pancreatitis, inflammatory delineation with pseudocyst formation occurred in 2 patients during complex treatment including thymalin.

    In plain wordsIn patients with acute necrotic pancreatitis, pseudocyst formation occurred in 2 patients during complex treatment including thymalin.

    Peptide
    Thymalin
    Outcome
    Not applicablePancreatic pseudocyst formation
    Study

    n = 18

    Outcome group
    Overall treatment effect · Gastrointestinal

    Measurements

    Patients with pseudocyst formation
    2 patients
    complex treatment including thymalin
    Pseudocyst formation proportion
    11.1%
    complex treatment including thymalin

    Source sentences

    Summary
    in 2 (11.1%)--the inflammatory process delineation with pancreatic pseudocyst formation was observed
    1 context sentence
    Summary · context
    Analysis of efficacy of the immunomodulators application, thymalin in particular, in complex treatment algorhythm in 18 patients with an acute necrotic pancreatitis was conducted.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  4. 04HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In acute necrotic pancreatitis, 4 patients underwent surgery during complex treatment with immunomodulators including thymalin.

    In plain wordsIn patients with acute necrotic pancreatitis, 4 patients underwent surgery during complex treatment including thymalin.

    Peptide
    Thymalin
    Outcome
    Not applicableSurgical intervention
    Study

    n = 18

    Outcome group
    Overall treatment effect · Gastrointestinal

    Measurements

    Patients operated on
    4 patients
    complex treatment including thymalin
    Surgery proportion
    22.2%
    complex treatment including thymalin

    Source sentences

    Summary
    4 (22.2%) patients were operated on.
    1 context sentence
    Summary · context
    Analysis of efficacy of the immunomodulators application, thymalin in particular, in complex treatment algorhythm in 18 patients with an acute necrotic pancreatitis was conducted.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  5. 05HumanNot a test of Thymalin aloneNon-randomized trialSafety outcome

    All patients with acute necrotic pancreatitis survived during complex treatment with immunomodulators including thymalin.

    In plain wordsAll patients with acute necrotic pancreatitis survived during complex treatment including thymalin.

    Peptide
    Thymalin
    Outcome
    Not applicableSurvival
    Study

    n = 18

    Outcome group
    Mortality · Whole body

    Source sentences

    Summary
    All the patients survived.
    1 context sentence
    Summary · context
    Analysis of efficacy of the immunomodulators application, thymalin in particular, in complex treatment algorhythm in 18 patients with an acute necrotic pancreatitis was conducted.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.